Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
L3Harris
LHX
|
+$148M |
| 2 |
GE HealthCare
GEHC
|
+$118M |
| 3 |
Atlassian
TEAM
|
+$101M |
| 4 |
Axon Enterprise
AXON
|
+$23.7M |
| 5 |
Reliance Steel & Aluminium
RS
|
+$22.4M |
Top Sells
| 1 |
Apple
AAPL
|
+$360M |
| 2 |
Microsoft
MSFT
|
+$199M |
| 3 |
GE Aerospace
GE
|
+$131M |
| 4 |
NVIDIA
NVDA
|
+$99.2M |
| 5 |
Amazon
AMZN
|
+$85.4M |
Sector Composition
| 1 | Technology | 28.64% |
| 2 | Healthcare | 14.81% |
| 3 | Consumer Discretionary | 11.76% |
| 4 | Industrials | 9.44% |
| 5 | Communication Services | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Warby Parker
WRBY
$3.28B
| $1.54M | ﹤0.01% |
145,000
-16,900
| -10% | -$179K |
|
2002
Banc of California
BANC
$2.62B
| $1.53M | ﹤0.01% |
122,400
-14,800
| -11% | -$185K |
|
|
NGD
2003
New Gold Inc
NGD
$5.17B
| $1.53M | ﹤0.01% |
1,411,562
-161,000
| -10% | -$175K |
|
2004
OrthoPediatrics
KIDS
$492M
| $1.53M | ﹤0.01% |
34,600
+300
| +0.9% | +$13.3K |
|
2005
Kura Oncology
KURA
$726M
| $1.53M | ﹤0.01% |
125,300
-12,000
| -9% | -$147K |
|
2006
TFS Financial
TFSL
$3.78B
| $1.53M | ﹤0.01% |
121,000
-14,500
| -11% | -$183K |
|
2007
Jamf
JAMF
$1.37B
| $1.53M | ﹤0.01% |
78,600
-8,800
| -10% | -$171K |
|
2008
Innoviva
INVA
$1.22B
| $1.53M | ﹤0.01% |
135,600
-15,900
| -10% | -$179K |
|
2009
Keros Therapeutics
KROS
$640M
| $1.52M | ﹤0.01% |
35,700
-1,600
| -4% | -$68.3K |
|
|
EFXT
2010
Enerflex
EFXT
$1.29B
| $1.52M | ﹤0.01% |
255,900
-29,200
| -10% | -$174K |
|
2011
CEVA Inc
CEVA
$568M
| $1.52M | ﹤0.01% |
50,000
-6,100
| -11% | -$186K |
|
2012
QCR Holdings
QCRH
$1.31B
| $1.52M | ﹤0.01% |
34,639
-4,100
| -11% | -$180K |
|
2013
TTEC Holdings
TTEC
$173M
| $1.52M | ﹤0.01% |
40,700
-4,900
| -11% | -$182K |
|
|
EFC
2014
Ellington Financial
EFC
$1.35B
| $1.51M | ﹤0.01% |
124,000
-13,600
| -10% | -$166K |
|
2015
Columbia Financial
CLBK
$1.61B
| $1.51M | ﹤0.01% |
82,688
-10,300
| -11% | -$188K |
|
|
PDS
2016
Precision Drilling
PDS
$770M
| $1.51M | ﹤0.01% |
29,400
-3,600
| -11% | -$185K |
|
2017
BioLife Solutions
BLFS
$1.23B
| $1.51M | ﹤0.01% |
69,300
-7,800
| -10% | -$170K |
|
|
AMK
2018
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $1.51M | ﹤0.01% |
47,900
-5,600
| -10% | -$176K |
|
2019
Ambac
AMBC
$414M
| $1.5M | ﹤0.01% |
97,000
-11,500
| -11% | -$178K |
|
2020
Regenxbio
RGNX
$464M
| $1.5M | ﹤0.01% |
79,400
-9,300
| -10% | -$176K |
|
2021
Eventbrite
EB
$262M
| $1.5M | ﹤0.01% |
174,900
-19,700
| -10% | -$169K |
|
2022
Univest Financial
UVSP
$889M
| $1.5M | ﹤0.01% |
63,078
-7,800
| -11% | -$185K |
|
|
ARR
2023
Armour Residential REIT
ARR
$1.72B
| $1.5M | ﹤0.01% |
57,042
+1,680
| +3% | +$44.1K |
|
2024
Metallus
MTUS
$701M
| $1.5M | ﹤0.01% |
81,600
-12,400
| -13% | -$227K |
|
|
SP
2025
DELISTED
SP Plus Corporation
SP
| $1.49M | ﹤0.01% |
43,500
-12,700
| -23% | -$435K |
|